Additional file 3 of Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial

Autor: Baltrusaitis, Kristin, Makanani, Bonus, Tierney, Camlin, Fowler, Mary Glenn, Moodley, Dhayendre, Theron, Gerhard, Nyakudya, Lynette H., Tomu, Musunga, Fairlie, Lee, George, Kathleen, Heckman, Barbara, Knowles, Kevin, Browning, Renee, Siberry, George K., Taha, Taha E., Stranix-Chibanda, Lynda

Additional file 3: Additional Baseline Characteristics.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::733c32df1ec3c0f1a49ade327d527105

Additional file 4 of Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial

Autor: Baltrusaitis, Kristin, Makanani, Bonus, Tierney, Camlin, Fowler, Mary Glenn, Moodley, Dhayendre, Theron, Gerhard, Nyakudya, Lynette H., Tomu, Musunga, Fairlie, Lee, George, Kathleen, Heckman, Barbara, Knowles, Kevin, Browning, Renee, Siberry, George K., Taha, Taha E., Stranix-Chibanda, Lynda

Additional file 4: Table S1. PROMISE Study Follow-up Time and Tenofovir Disoproxil Fumarate (TDF) Exposure for Women Eligible for TDF Randomization.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::375197e169da63a86357696097b1e4d6

Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial.

Autor: Baltrusaitis K; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, 651 Huntington Avenue, Boston, MA, 02115, USA. kbaltrus@sdac.harvard.edu., Makanani B; College of Medicine, University of Malawi, Blantyre, Malawi., Tierney C; Center for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, 651 Huntington Avenue, Boston, MA, 02115, USA., Fowler MG; Department of Pathology, Johns Hopkins University, Baltimore, MD, USA., Moodley D; Centre for AIDS Prevention Research in South Africa and Department of Obstetrics and Gynecology, School of Clinical Medicine, University of KwaZulu Natal, Durban, South Africa., Theron G; Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Nyakudya LH; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Tomu M; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe., Fairlie L; Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., George K; FHI 360, Durham, NC, USA., Heckman B; Frontier Science Foundation, Amherst, NY, USA., Knowles K; Frontier Science Foundation, Amherst, NY, USA., Browning R; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Siberry GK; United States Agency for International Development, Washington, DC, USA., Taha TE; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Stranix-Chibanda L; University of Zimbabwe Clinical Trials Research Centre, Harare, Zimbabwe.; Child and Adolescent Health Unit, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2022 Jul 20; Vol. 22 (1), pp. 634. Date of Electronic Publication: 2022 Jul 20.